RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
161 hedge funds and large institutions have $731M invested in Revance Therapeutics, Inc. in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 61 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
21% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 61
28% less capital invested
Capital invested by funds: $1.02B → $731M (-$284M)
Holders
161
Holding in Top 10
2
Calls
$14.1M
Puts
$12.8M
Top Buyers
| 1 | +$17.1M | |
| 2 | +$6.01M | |
| 3 | +$5.5M | |
| 4 |
Millennium Management
New York
|
+$4.65M |
| 5 |
BAMCO Inc
New York
|
+$4.02M |
Top Sellers
| 1 | -$30.1M | |
| 2 | -$9.47M | |
| 3 | -$9.18M | |
| 4 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$3.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.51M |